New enzyme therapy aims to help cystic fibrosis patients digest food
Disease control
Not yet recruiting
This study is testing whether a new enzyme therapy called ANG003 works as well as the standard treatment (Creon) for people with cystic fibrosis who have trouble digesting food. About 113 participants aged 12+ with cystic fibrosis and severe pancreatic insufficiency will try eith…
Phase: PHASE2 • Sponsor: Anagram Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC